Differential Diagnosis of Muscle Weakness in Myasthenia Gravis, Polymyositis and Muscular Dystrophy

作者: John S. Garvin

DOI: 10.1016/S0025-7125(16)33360-0

关键词:

摘要:

参考文章(33)
H.C. Churchill-Davidson, A.T. Richardson, Myasthenic crisis; therapeutic use of d-tubocurarine. The Lancet. ,vol. 269, pp. 1221- 1224 ,(1957) , 10.1016/S0140-6736(57)91791-9
Geoffrey Keynes, Surgery of the thymus gland: second (and third) thoughts The Lancet. ,vol. 263, pp. 1197- 1202 ,(1954) , 10.1016/S0140-6736(54)92441-1
The place of corticotropin in the treatment of myasthenia gravis. Annals of Internal Medicine. ,vol. 52, pp. 806- 818 ,(1960) , 10.7326/0003-4819-52-4-806
William M. Fowler, Wendell H. Griffith, Carl M. Pearson, Sudhir R. Chowdhury, Margaret H. Jones, STUDIES OF ENZYMES IN SERUM IN MUSCULAR DYSTROPHY: II. Diagnostic and Prognostic Significance in Relatives of Dystrophic Persons Pediatrics. ,vol. 28, pp. 962- 970 ,(1961)
B P Hughes, Serum enzyme changes in muscle disease and their relation to tissue change. Journal of the Royal Society of Medicine. ,vol. 56, pp. 179- 182 ,(1963) , 10.1177/003591576305600318
Robert S. Schwab, Management of myasthenia gravis. The New England Journal of Medicine. ,vol. 268, pp. 596- 597 ,(1963) , 10.1056/NEJM196303142681107
R. P. Wise, V. MacDermot, A myasthenic syndrome associated with bronchial carcinoma. Journal of Neurology, Neurosurgery, and Psychiatry. ,vol. 25, pp. 31- 39 ,(1962) , 10.1136/JNNP.25.1.31